Clinical Trial Update: A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV [NA]

View source ↗

Summary

Clinical study evaluating Gecacitinib combined with Pegylated Interferon in Polycythemia Vera; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Gecacitinib (Gecacitinib)
• Pegylated interferon (pegylated interferon alfa)

Snippet

Sponsor: Duan Minghui | Conditions: Polycythemia Vera (PV) | NA | Status: NOT_YET_RECRUITING